David Malcom Rodman
CIK 1672659 · Chief Medical Officer · last filed 2026-05-19
David Malcom Rodman is a Chief Medical Officer who has filed 55 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for MLYS, was dated May 19, 2026. Across all open-market trades the lifetime net is −$18.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.51M
2
55
-$18.82M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLYS | Chief Medical Officer | 63,860 | $23.62 | $1.51M | -$18.73M | 51 | 2026-05-19 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Exec Vice President and CMO | 11,368 | — | — | -$89.2K | 4 | 2017-01-05 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-19 | MLYS | Mixed | — | -$5.0K | EDGAR |
| 2026-05-13 | MLYS | Mixed | −6,349 | -$515.6K | EDGAR |
| 2026-04-21 | MLYS | Mixed | — | -$6.6K | EDGAR |
| 2026-04-15 | MLYS | Mixed | −6,348 | -$446.3K | EDGAR |
| 2026-04-13 | MLYS | Mixed | — | -$24.7K | EDGAR |
| 2026-03-17 | MLYS | Mixed | — | -$4.3K | EDGAR |
| 2026-03-16 | MLYS | Mixed | −6,349 | -$440.6K | EDGAR |
| 2026-03-10 | MLYS | Mixed | — | -$23.5K | EDGAR |
| 2026-02-20 | MLYS | Grant (A) | +38,400 | $0 | EDGAR |
| 2026-02-17 | MLYS | Mixed | — | -$5.1K | EDGAR |